Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH3D

N-(2-Cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoropropanamide

PubChem 71811910
was used by NIH 3D workflows to automatically generate models for
Gerald Artman
Created:
4/9/25
Submitted:
10/9/26
Published:
10/9/26

Select an image below to view

Learn more about NIH 3D workflow outputs

3DPX-021827

Licensing:

CC-BY
147
61
Version 2

Category

Small Molecules
Small Molecules
Description

Omaveloxolone is a semi-synthetic triterpenoid drug. It is an Nrf2 activator that is approved for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older. It has a role as an antioxidant, an antineoplastic agent, an anti-inflammatory agent and a cardioprotective agent. It is a secondary carboxamide, a nitrile, a pentacyclic triterpenoid, a cyclic terpene ketone and an organofluorine compound. It derives from a hydride of an oleanane.
https://pubchem.ncbi.nlm.nih.gov/image/imagefly.cgi?cid=71811910&width=400&height=400